Roger D. Norcross

4.2k citations

33 papers · 2.8k indexed · h-index 21

Organic Chemistry top 1%
Molecular Biology top 10%
Cellular and Molecular Neuroscience top 2%
Biotechnology top 2%
Pharmacology top 5%

Co-authors: Ian Paterson Marius C. Hoener Peter Matt David A. Evans Scott J. Miller Jerry A. Murry M. A. LISTER Joseph G. Wettstein
Topics: Asymmetric Synthesis and Catalysis (11 papers)Synthetic Organic Chemistry Methods (10 papers)Receptor Mechanisms and Signaling (10 papers)
Cited by: Organic Chemistry Cellular and Molecular Neuroscience Biotechnology
Journals: Chemical Reviews Proceedings of the National Academy of Sciences Journal of the American Chemical Society
Partner nations: Switzerland United States United Kingdom

In The Last Decade

Roger D. Norcross

33 papers receiving 2.7k citations

Peers

Countries citing papers authored by Roger D. Norcross

Since Specialization

Citations

This map shows the geographic impact of Roger D. Norcross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger D. Norcross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger D. Norcross more than expected).

Fields of papers citing papers by Roger D. Norcross

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger D. Norcross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger D. Norcross. The network helps show where Roger D. Norcross may publish in the future.

Co-authorship network of co-authors of Roger D. Norcross

This figure shows the co-authorship network connecting the top 25 collaborators of Roger D. Norcross. A scholar is included among the top collaborators of Roger D. Norcross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger D. Norcross. Roger D. Norcross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis of enantiomerically pure [¹⁴C]‐labelled morpholine derivatives for a class of trace amine‐associate receptor 1 agonists 2016 ·Journal of Labelled Compounds and Radiopharmaceuticals ·(unknown),Thomas Härtung,René Trussardi,Hans Iding,Guido Galley,Philippe Pflieger,Roger D. Norcross	5
2	Incretin-like effects of small molecule trace amine-associated receptor 1 agonists 2015 ·Molecular Metabolism ·S. Raab,Haiyan Wang,Sabine Uhles,(unknown),Rubén Alvarez‐Sánchez,Basil Künnecke,Christoph Ullmer,Hugues Matile,Marc Bedoucha,Roger D. Norcross,(unknown),Diego Pérez–Tilve,(unknown),Matthias H. Tschöp,Marius C. Hoener,Sabine Sewing	78
3	A UGT2B10 Splicing Polymorphism Common in African Populations May Greatly Increase Drug Exposure 2014 ·Journal of Pharmacology and Experimental Therapeutics ·Stephen Fowler,Heidemarie Kletzl,Moshe Finel,Nenad Manevski,P. E. Schmid,Dietrich Tuerck,Roger D. Norcross,Marius C. Hoener,Olivia Spleiss,Victor A. Iglesias	47
4	Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine 2012 ·Neuropsychopharmacology ·Florent G. Revel,Claas A. Meyer,Amyaouch Bradaïa,Karine Jeanneau,Eleonora Calcagno,C. André,(unknown),(unknown),Guido Galley,Roger D. Norcross,Roberto William Invernizzi,Joseph G. Wettstein,Jean-Luc Moreau,Marius C. Hoener	84
5	A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight 2012 ·Molecular Psychiatry ·(unknown),J‐L Moreau,Bruno Pouzet,Roland Mory,Amyaouch Bradaïa,(unknown),(unknown),Sylvie Chaboz,Katrin Groebke Zbinden,Guido Galley,Roger D. Norcross,Dietrich Tuerck,Andreas Bruns,Stephen R. Morairty,Thomas S. Kilduff,Tanya L. Wallace,Céline Risterucci,Joseph G. Wettstein,Marius C. Hoener	211
6	Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics 2012 ·Biological Psychiatry ·Florent G. Revel,Jean‐Luc Moreau,Raul R. Gainetdinov,Antonio Ferragud,Clara Velázquez-Sánchez,Tatyana D. Sotnikova,Stephen R. Morairty,Anja Harmeier,Katrin Groebke Zbinden,Roger D. Norcross,Amyaouch Bradaïa,Thomas S. Kilduff,Barbara Biemans,Bruno Pouzet,Marc G. Caron,Juan J. Canales,Tanya L. Wallace,Joseph G. Wettstein,Marius C. Hoener	144
7	Optimisation of imidazole compounds as selective TAAR1 agonists: Discovery of RO5073012 2012 ·Bioorganic & Medicinal Chemistry Letters ·Guido Galley,Henri Stalder,(unknown),Marius C. Hoener,Roger D. Norcross	46
8	Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773) 2010 ·Bioorganic & Medicinal Chemistry Letters ·Henri Stalder,Marius C. Hoener,Roger D. Norcross	47
9	4-Substituted-7-N-alkyl-N-acetyl 2-aminobenzothiazole amides: Drug-like and non-xanthine based A2B adenosine receptor antagonists 2010 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),J. A. Brinkman,(unknown),Alexander Flohr,Joseph Grimsby,(unknown),Kevin R. Guertin,Rachid Hamid,(unknown),Roger D. Norcross,Lida Qi,(unknown),Jenny Tan,Wen Yang,Ramakanth Sarabu	9
10	Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Emmanuel Pinard,Daniela Alberati,Edilio Borroni,Holger Fischer,Dominik Hainzl,Synèse Jolidon,Jean‐Luc Moreau,Robert Narquizian,Matthias Nettekoven,Roger D. Norcross,Henri Stalder,Andrew W. Thomas	18
11	Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABA_Breceptors 2008 ·British Journal of Pharmacology ·Pari Malherbe,Raffaello Masciadri,Roger D. Norcross,Frédéric Knoflach,Claudia Kratzeisen,(unknown),(unknown),Anne Marcuz,Jörg Huwyler,(unknown),Richard H. Porter,Andrew W. Thomas,Joseph G. Wettstein,Andrew J. Sleight,Will Spooren,E. Prinssen	85
12	Design, synthesis and structure–activity relationship of simple bis-amides as potent inhibitors of GlyT1 2008 ·Bioorganic & Medicinal Chemistry Letters ·Synèse Jolidon,Daniela Alberati,Adam Dowle,Holger Fischer,Dominik Hainzl,Robert Narquizian,Roger D. Norcross,Emmanuel Pinard	15
13	The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the AB-spiroacetal segment 2005 ·Organic & Biomolecular Chemistry ·Ian Paterson,Mark J. Coster,David Y.‐K. Chen,Renata M. Oballa,Debra J. Wallace,Roger D. Norcross	37
14	Stereocontrolled Total Synthesis of (+)-Altohyrtin A/Spongistatin 1 Financial support was provided by the EPSRC (GR/L41646), Cambridge Commonwealth Trust (Scholarship to M.J.C.), EC (Marie Curie Postdoctoral Fellowship to J.L.A.), DFG (Postdoctoral Fellowship to T.T.), NSERC-Canada (Postdoctoral Fellowship to R.M.O.), Churchill College (Research Fellowship to D.J.W.), Kingapos;s College and Sims Fund, Cambridge (Scholarship to D.Y.K.C.). We also thank Merck and AstraZeneca Pharmaceuticals for generous support, and Dr. Anne Butlin (AZ) and Dr. Nick Bampos (Cambridge) for valuable assistance. 2001 ·Angewandte Chemie International Edition ·Ian Paterson,David Y.‐K. Chen,Mark J. Coster,José Luis Aceña,Jordi Bach,Karl R. Gibson,Linda E. Keown,Renata M. Oballa,Thomas Trieselmann,Debra J. Wallace,(unknown),Roger D. Norcross	94
15	Bis(oxazoline) and Bis(oxazolinyl)pyridine Copper Complexes as Enantioselective Diels−Alder Catalysts: Reaction Scope and Synthetic Applications 1999 ·Journal of the American Chemical Society ·David A. Evans,David M. Barnes,Jeffrey S. Johnson,Thomas Lectka,Peter Matt,Scott J. Miller,Jerry A. Murry,Roger D. Norcross,(unknown),Kevin R. Campos	214
16	Synthesis of novel cyclobutylphosphonic acids as inhibitors of imidazole glycerol phosphate dehydratase 1997 ·Tetrahedron ·Roger D. Norcross,Peter Matt,Hartmuth C. Kolb,D. BELLUS	14
17	Studies in marine macrolide synthesis: Stereocontrolled synthesis of the AB-spiroacetal subunit of spongistatin 1 (altohyrtin A) 1996 ·Tetrahedron Letters ·Ian Paterson,Renata M. Oballa,Roger D. Norcross	88
18	C₂‐Symmetrische, kationische Kupfer(II)‐Komplexe als chirale Lewis‐Säuren – Einfluß des Gegenions bei enantioselektiven Diels‐Alder‐Reaktionen 1995 ·Angewandte Chemie ·David A. Evans,Jerry A. Murry,Peter Matt,Roger D. Norcross,Scott J. Miller	48
19	Studies in Macrolide Synthesis: A Stereocontrolled Synthesis of Oleandolide Employing Reagent- and Substrate-Controlled Aldol Reactions of (S)-1-(Benzyloxy)-2-methylpentan-3-one 1994 ·Journal of the American Chemical Society ·Ian Paterson,Roger D. Norcross,Richard A. Ward,Pedro Romea,M. A. LISTER	120
20	Studies in macrolide synthesis: A stereocontrolled synthesis of a (9S)-macrolide intermediate for oleandomycin using chiral boron reagents. 1992 ·Tetrahedron Letters ·Ian Paterson,M. A. LISTER,Roger D. Norcross	11

About Roger D. Norcross

Roger D. Norcross is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Biochemistry, having authored 33 papers that have together received 2.8k indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (11 papers), Synthetic Organic Chemistry Methods (10 papers) and Receptor Mechanisms and Signaling (10 papers). The work is most often cited by research in Organic Chemistry (1.5k citations), Cellular and Molecular Neuroscience (907 citations) and Biotechnology (296 citations). Roger D. Norcross has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Ian Paterson, Marius C. Hoener, Peter Matt, David A. Evans, Scott J. Miller, Jerry A. Murry, M. A. LISTER, Joseph G. Wettstein, Amyaouch Bradaïa and Renata M. Oballa. Their work appears in journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact